Switch to Tirzepatide in T2D More Effective Than Upping Dulaglutide Dose
9 Articles
9 Articles
Switch to Tirzepatide in T2D More Effective Than Upping Dulaglutide Dose
(MedPage Today) -- Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide (Mounjaro) rather than increasing the dose of the earlier-generation GLP-1 receptor agonist, an open...
Newswise Latest News: news and press releases in science, medicine, life, and business
For patients with inadequately controlled type 2 diabetes, switching to tirzepatide improves glucose control and increases weight loss more so than maximizing dulaglutide dose.


Switching to Tirzepatide Outweighs Upping Dulaglutide Dose
The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers. Medscape Medical News
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage